Molecular characterization of a Leishmania donovanii cDNA clone with similarity to human 20S proteasome a-type subunit

被引:17
作者
Christensen, CBV
Jorgensen, L
Jensen, ATR
Gasim, S
Chen, M
Kharazmi, A
Theander, TG
Andresen, K
机构
[1] Univ Copenhagen, Ctr Med Parasitol, Inst Med Microbiol & Immunol, DK-2200 Copenhagen N, Denmark
[2] Univ Copenhagen Hosp, Rigshosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark
[3] Univ Copenhagen Hosp, Rigshosp, Dept Clin Microbiol, DK-2100 Copenhagen, Denmark
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 2000年 / 1500卷 / 01期
关键词
Leishmania; cDNA library; proteasome a-subunit; DNA vaccination;
D O I
10.1016/S0925-4439(99)00086-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Using plasma from patients infected or previously infected with Leishmania donovanii, we isolated a L. donovanii cDNA clone with similarity to the proteasome a-type subunit from humans and other eukaryotes, The cDNA clone, designated LePa, was DNA sequenced and Northern blot analysis of L. donovanii poly(A(+))mRNA indicated the isolation of a full length cDNA clone with a transcript size of 1.9 kb. The expressed recombinant LePa fusion protein induced proliferation of peripheral blood mononuclear cells in one out of seven patients who had suffered from visceral leishmaniasis. Plasma from 16 out of 25 patients with visceral leishmaniasis and four out of 18 patients with cutaneous leishmaniasis contained IgG antibodies which reacted with the purified LePa fusion protein as evaluated in an ELISA. The LePa DNA sequence was inserted into an eukaryotic expression vector and Balb/c mice were vaccinated. DNA vaccination of Balb/c mice with LePa generated an initial significant reduction in lesion size after challenge. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:77 / 87
页数:11
相关论文
共 36 条
[11]  
GAAFAR A, 1995, CLIN EXP IMMUNOL, V100, P239
[12]  
Gasim S, 1998, CLIN EXP IMMUNOL, V111, P64
[13]   Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major [J].
Gurunathan, S ;
Sacks, DL ;
Brown, DR ;
Reiner, SL ;
Charest, H ;
Glaichenhaus, N ;
Seder, RA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (07) :1137-1147
[14]   LEISHMANIA-MAJOR - PRODUCTION OF RECOMBINANT GP63, ITS ANTIGENICITY AND IMMUNOGENICITY IN MICE [J].
HANDMAN, E ;
BUTTON, LL ;
MCMASTER, RW .
EXPERIMENTAL PARASITOLOGY, 1990, 70 (04) :427-435
[15]  
Hilt W, 1996, ADV EXP MED BIOL, V389, P197
[16]   TRANSIENT DEPLETION OF T-CELLS WITH HIGH LFA-1 EXPRESSION FROM PERIPHERAL-CIRCULATION DURING ACUTE PLASMODIUM-FALCIPARUM MALARIA [J].
HVIID, L ;
THEANDER, TG ;
ABDULHADI, NH ;
ABUZEID, YA ;
BAYOUMI, RA ;
JENSEN, JB .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1991, 21 (05) :1249-1253
[17]  
JAFFE CL, 1990, J IMMUNOL, V144, P699
[18]   Serodiagnosis of cutaneous leishmaniasis: Assessment of an enzyme-linked immunosorbent assay using a peptide sequence from gene B protein [J].
Jensen, ATR ;
Gaafar, A ;
Ismail, A ;
Christensen, CBV ;
Kemp, M ;
ElHassan, AM ;
Kharazami, A ;
Theander, TG .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1996, 55 (05) :490-495
[19]   MOLECULAR-CLONING AND CHARACTERIZATION OF A LEISHMANIA-DONOVANI ALPHA-TUBULIN GENE [J].
JOSHI, M ;
DWYER, DM ;
NAKHASI, HL .
JOURNAL OF EUKARYOTIC MICROBIOLOGY, 1995, 42 (05) :628-632
[20]  
Kemp M, 1998, FEMS IMMUNOL MED MIC, V20, P209, DOI 10.1111/j.1574-695X.1998.tb01129.x